Company Overview of Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc. operates as a cardiovascular drug development company that develops novel small molecule therapeutics. It offers a novel and potent short-acting calcium channel antagonist for the treatment of transient cardiovascular conditions, such as paroxysmal supraventricular tachycardia by the termination of acute episodes of atrial tachycardia in patients. The company was founded in 2005 and is based in Saint-Laurent, Canada.
1111 Dr.-Frederik-Philips Boulevard
Saint-Laurent, QC H4M 2X6
Founded in 2005
Key Executives for Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc. Key Developments
Similar Private Companies By Industry
|Dragon Pharmaceutical Inc.||Americas|
|Intervet Canada Corp.||Americas|
|Medical Futures Inc.||Americas|
Recent Private Companies Transactions
June 3, 2015
To contact Milestone Pharmaceuticals Inc., please visit www.milestonepharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.